Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
pubmed.ncbi.nlm.nih.gov/29782846 Chang CH, et al
By developing algorithm-based methods to optimize multi-targeted drug design and enhancing translational research from preclinical to clinical stages, we will aim to address challengessuch as genomic, proteomic, and clinical data diversity and off-target effects ( 2 Technologies 2.1 Omics strategies Omics data, the product of high-throughput technologies, originate from various fields such as genomics, proteomics and metabolomics, and holds significant value in drug research (Zhang et al., 2024)
Who can benefit from ARA-290 Based on clinical research and mechanism of action, several populations may find ARA-290 particularly relevant
Data availability The data that support the findings of this study are available from Statistics Denmark
If so, then here are the specific nutrients you need to seek out right now
Accessed at pmc.ncbi.nlm.nih.gov/articles/PMC11034947
